162 related articles for article (PubMed ID: 36679960)
1. Recombinant GPEHT Fusion Protein Derived from HTLV-1 Proteins with Alum Adjuvant Induces a High Immune Response in Mice.
Jahantigh HR; Stufano A; Koohpeyma F; Nikbin VS; Shahosseini Z; Lovreglio P
Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679960
[TBL] [Abstract][Full Text] [Related]
2. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
[TBL] [Abstract][Full Text] [Related]
3. Formulation of a recombinant HIV-1 polytope candidate vaccine with naloxone/alum mixture: induction of multi-cytokine responses with a higher regulatory mechanism.
Fathi M; Nezamzadeh R; Abdollahpour-Alitappeh M; Yazdi MH; Khoramabadi N; Mahdavi M
APMIS; 2021 Aug; 129(8):480-488. PubMed ID: 33539574
[TBL] [Abstract][Full Text] [Related]
4. Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (
Shafifar M; Mozhgani SH; Razavi Pashabayg K; Mosavat A; Karbalaei M; Norouzi M; Rezaee SA
Life Sci; 2022 Nov; 308():120920. PubMed ID: 36044973
[TBL] [Abstract][Full Text] [Related]
5. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
Kabiri M; Sankian M; Sadri K; Tafaghodi M
Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses.
Haghighi M; Khorasani A; Karimi P; Mahdavi M
Iran J Basic Med Sci; 2022 May; 25(5):554-561. PubMed ID: 35911642
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of human papilloma vaccine candidate using naloxone/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine.
Yasaghi M; Mahdavi M
Iran J Basic Med Sci; 2016 Sep; 19(9):1003-1009. PubMed ID: 27803788
[TBL] [Abstract][Full Text] [Related]
8. Single-stranded RNA adjuvant enhances the efficacy of 10-valent human papilloma virus-like particle vaccine.
Kwak HW; Shin W; Baik K; Kim M; Park Y; Hong SH; Park HJ; Park HJ; Bang YJ; Kim JY; Lee YS; Kim IB; Kim HL; Kim H; Nam JH
Microbiol Immunol; 2022 Nov; 66(11):529-537. PubMed ID: 35979884
[TBL] [Abstract][Full Text] [Related]
9. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
Dinc G; Pennington JM; Yolcu ES; Lawrenz MB; Shirwan H
Vaccine; 2014 Sep; 32(39):5035-40. PubMed ID: 25045812
[TBL] [Abstract][Full Text] [Related]
10. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
11. The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1.
Kabiri M; Sankian M; Hosseinpour M; Tafaghodi M
Int J Pharm; 2018 Oct; 549(1-2):404-414. PubMed ID: 30075250
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to HIV-1 polytope vaccine candidate formulated in aqueous and alcoholic extracts of Propolis: Comparable immune responses to Alum and Freund adjuvants.
Mojarab S; Shahbazzadeh D; Moghbeli M; Eshraghi Y; Bagheri KP; Rahimi R; Savoji MA; Mahdavi M
Microb Pathog; 2020 Mar; 140():103932. PubMed ID: 31857237
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
[TBL] [Abstract][Full Text] [Related]
14. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
[TBL] [Abstract][Full Text] [Related]
15. PPD in HBsAg vaccine formulation suppressed IFN-γ and IL-4 cytokine responses and induced long-lived humoral immune responses: Results from 220-day monitoring of specific IgG responses.
Mirzaee R; Nemati F; Mirzaee M; Golkaran B; Khorasani A; Rashedi N; Asgarhalvaei F; Savoji MA; Mahdavi M
Iran J Basic Med Sci; 2022 Nov; 25(11):1326-1333. PubMed ID: 36474577
[TBL] [Abstract][Full Text] [Related]
16. Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses.
Haghighi M; Khorasani A; Karimi P; Keshavarz R; Mahdavi M
Viral Immunol; 2022 Dec; 35(10):663-672. PubMed ID: 36534465
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
Shokouhi H; Farahmand B; Ghaemi A; Mazaheri V; Fotouhi F
Virus Res; 2018 Jun; 251():40-46. PubMed ID: 29730305
[TBL] [Abstract][Full Text] [Related]
18. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
19. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
